Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
Type
Guidance (794)
Guidance programme
(
2 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (766)
Apply filters
Showing 601 to 610 of 794
Sort by
Date
Title
Apply sorting
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Panobinostat for treating multiple myeloma after at least 2 previous treatments
TA380
27 January 2016
27 January 2016
Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal)
TA382
27 January 2016
27 January 2016
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
TA375
26 January 2016
26 January 2016
Guidance on the use of imatinib for chronic myeloid leukaemia
TA70
22 October 2003
21 January 2016
Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears
TA369
16 December 2015
16 December 2015
Bortezomib for previously untreated mantle cell lymphoma
TA370
16 December 2015
16 December 2015
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis
TA373
16 December 2015
16 December 2015
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy
TA374
16 December 2015
16 December 2015
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
TA365
25 November 2015
25 November 2015
Vortioxetine for treating major depressive episodes
TA367
25 November 2015
25 November 2015
Previous page
1
…
59
60
Current page
61
62
63
…
80
Page
61
of
80
Next page
Results per page
10
25
50
All
Back to top